Person

Charles A. Baker

Formerly Director, Regeneron Pharmaceuticals

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$2.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Sep 29, 2017REGNSale2,000$450.00$900K
Dec 12, 2016REGNSale600$390.67$234K
Dec 12, 2016REGNSale200$394.33$79K
Dec 12, 2016REGNSale400$392.41$157K
Dec 12, 2016REGNSale600$393.64$236K
Dec 12, 2016REGNSale1,200$391.36$470K

SEC reporting-owner ID (CIK) 1225470 · all filings on EDGAR

Charles A. Baker | USBoard